Ronald Kirk Huntsman - 10 Dec 2020 Form 3/A - Amendment Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Chairman and CEO, Director, 10%+ Owner
Signature
/s/ R. Kirk Huntsman
Issuer symbol
VVOS
Transactions as of
10 Dec 2020
Net transactions value
$0
Form type
3/A - Amendment
Filing time
29 Jun 2021, 16:18:15 UTC
Date Of Original Report
10 Dec 2020
Next filing
25 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VVOS Common Stock 1,740,000 10 Dec 2020 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment to Form 3 is being filed by the reporting person to correct an inadvertent over reporting (by an aggregate of 9,000 shares) of the number of shares of common stock indirectly owned by the reporting person as of the initial reporting date.
F2 Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.